110345-43-2 Usage
Uses
Used in Pharmaceutical Research:
Glycine, N,N'-[[[(4-methylphenyl)sulfonyl]imino]di-2,1-ethanediyl]bis[N-[(4-methylphenyl)sulfonyl]-, dimethyl ester is used as a research compound for its potential applications in the development of new pharmaceuticals. The presence of sulfonyl groups and the unique structure of the molecule make it a candidate for investigation in medicinal chemistry.
Used in Organic Synthesis:
In the field of organic synthesis, Glycine, N,N'-[[[(4-methylphenyl)sulfonyl]imino]di-2,1-ethanediyl]bis[N-[(4-methylphenyl)sulfonyl]-, dimethyl ester serves as a key intermediate or building block for the synthesis of more complex molecules. Its structural features, including the glycine backbone and sulfonyl groups, can be exploited to create novel compounds with potential applications in various industries.
Used in Chemical Research:
Glycine, N,N'-[[[(4-methylphenyl)sulfonyl]imino]di-2,1-ethanediyl]bis[N-[(4-methylphenyl)sulfonyl]-, dimethyl ester is used as a subject of study in chemical research to understand its reactivity, stability, and potential interactions with other molecules. This knowledge can contribute to the advancement of chemical science and the discovery of new applications for the compound.
Check Digit Verification of cas no
The CAS Registry Mumber 110345-43-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,3,4 and 5 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 110345-43:
(8*1)+(7*1)+(6*0)+(5*3)+(4*4)+(3*5)+(2*4)+(1*3)=72
72 % 10 = 2
So 110345-43-2 is a valid CAS Registry Number.
110345-43-2Relevant academic research and scientific papers
Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
-
, (2008/06/13)
The present invention is directed to low molecular weight mimics of superoxide dismutase (SOD) represented by the formula: STR1 wherein R, R', R1, R'1, R2, R'2, R3, R'3, R4, R'4, R5, R'5, R6, R'6, R7, R'7, R8, R'8, R9, and R'9 and X, Y, Z and n are as defined herein, useful as therapeutic agents for inflammatory disease states and disorders, ischemic/reperfusion injury, stroke, atherosclerosis, hypertension and all other conditions of oxidant-induced tissue damage or injury.
Methods of preparing manganese complexes of nitrogen-containing macrocyclic ligands
-
, (2008/06/13)
The present invention is directed to low molecular weight mimics of superoxide dismutase (SOD) represented by the formula: STR1 wherein R, R', R1, R'1, R2, R'2, R3, R'3, R4, R'4, R5, R'5, R6, R'6, R7, R'7, R8, R'8, R9, and R'9 and X, Y, Z and n are as defined herein, useful as therapeutic agents for inflammatory disease states and disorders, ischemic/reperfusion injury, stroke, atherosclerosis, hypertension and all other conditions of oxidant-induced tissue damage or injury.
